DelIVery for Pulmonary Arterial Hypertension (PAH) Clinical Study
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- Sponsors Medtronic
- 03 Aug 2016 New trial record
- 01 Jul 2016 Primary endpoint of rate of catheter-related complications per 1000 patient days has been met, according to results published in the Chest.
- 01 Jul 2016 Status changed from active, no longer recruiting to completed according to results published in the Chest.